What is Emergent Biosolutions's gain/loss on asset sales?

Emergent Biosolutions (EBS) reported gain/loss on asset sales of -$800K in Q1 2026.

How has Emergent Biosolutions's gain/loss on asset sales changed year-over-year?

Emergent Biosolutions's gain/loss on asset sales decreased by 166.7% year-over-year, from -$300K to -$800K.

What does gain/loss on asset sales mean?

Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.

Emergent Biosolutions EBS Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

AMP

Amphastar PharmaceuticalsAMPH

-$4K-100%

Opko HealthOPK

$34K-99.1%

Charles River LaboratoriesCRL

-$117.98M-3,595%

BrightSpring Health Services, Inc.BTSG

-$573K-267%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's gain/loss on asset sales?: Emergent Biosolutions (EBS) reported gain/loss on asset sales of -$800K in Q1 2026.
How has Emergent Biosolutions's gain/loss on asset sales changed year-over-year?: Emergent Biosolutions's gain/loss on asset sales decreased by 166.7% year-over-year, from -$300K to -$800K.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.